Test Price
2,800 AED✅ Home Collection Available
KRIT1 Gene Cerebral Cavernous Malformations Type 1 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين KRIT1 للتشوهات الكهفية الدماغية من النوع الأول في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-certified Next‑Generation Sequencing, validated against 2026 international genetic databases.
- Premium Logistics: Paid Hospital-Grade Home Collection with ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Post‑test telephonic guidance with a DHA‑licensed physician to interpret results and recommend next steps.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: اختبار جيني عالي الدقة بتقنية التسلسل الجيني من الجيل التالي (NGS) للكشف عن طفرات جين KRIT1 المرتبطة بالتشوهات الكهفية الدماغية من النوع الأول. يتضمن خدمة سحب منزلي معتمد، استشارة وراثية، وتوجيه طبي بعد الفحص وفقاً لأحدث تعليمات هيئة الصحة بدبي.
Overview
This KRIT1 Genetic Test detects pathogenic variants in the KRIT1 gene, responsible for familial Cerebral Cavernous Malformations Type 1 – a hereditary vascular disorder that leads to abnormal, leaky blood vessels in the brain and spinal cord. Using Next‑Generation Sequencing, it offers near‑complete coverage of the coding region and splice sites, confirming a genetic diagnosis with unmatched precision. تحليل جيني يهدف إلى تأكيد التشخيص الوراثي للتشوهات الكهفية الدماغية العائلية المرتبطة بطفرة جين KRIT1.
| Feature | Our KRIT1 NGS Test | Closest Alternative (MRI / Standard Panel) |
|---|---|---|
| Precision / Sensitivity | >99.9% analytical sensitivity for single‑nucleotide variants & small indels | Imaging visualises lesions but cannot confirm genetic cause; limited variant panels miss rare mutations |
| Methodology | Next‑Generation Sequencing (NGS) with full bioinformatics analysis | Sanger sequencing of selected exons or brain MRI/MRA |
| Turnaround | 3–4 Weeks | Varies; imaging immediate, but genetic confirmation may take 6–8 weeks if referred |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) notes: “A positive KRIT1 mutation confirms the hereditary form of cerebral cavernous malformations; however, clinical correlation with brain imaging and family history is essential. This test should be interpreted by a clinical geneticist or neurologist, and never as a standalone ‘peace of mind’ screen without proper counselling.”
⚠️ Medication & Safety Notice
Do not discontinue any prescribed medication without consulting your doctor. This genetic test does not require stopping antiplatelet or anticoagulant therapy.
- Exclusion Criteria: Minors (below 18) without a legal guardian’s informed consent; individuals unable to understand genetic counselling implications; samples collected during acute neurological crisis (e.g., acute stroke).
- ER Red Flags – Seek Immediate Medical Attention If You Experience: Sudden severe headache, seizure, new‑onset focal neurological deficit (weakness, numbness, vision loss), or unexplained loss of consciousness.
Patient FAQ & Clinical Guidance
1. What does the KRIT1 gene test detect?
This Next‑Generation Sequencing test identifies pathogenic variants in the KRIT1 gene responsible for familial cerebral cavernous malformations type 1, enabling accurate diagnosis and family risk assessment. يكتشف هذا الاختبار الطفرات المسببة للمرض في جين KRIT1 المرتبطة بالتشوهات الكهفية الدماغية الوراثية.
2. How is the sample collected?
A small blood sample, extracted DNA, or a single drop of blood on an FTA card is collected through a painless ISO‑certified home phlebotomy service, with no need to alter your medications. تُجمع العينة بسهولة عبر سحب دم منزلي معتمد دون الحاجة لإيقاف الأدوية.
3. Who should consider this genetic?
Individuals with multiple family members affected by cerebral cavernous malformations, those with a personal history of brain lesions on MRI, or relatives of a known mutation carrier should consider testing after mandatory genetic counselling. يُنصح بهذا الفحص للأشخاص الذين لديهم تاريخ عائلي من التشوهات الكهفية الدماغية أو أقارب لحامل طفرة مؤكدة بعد جلسة استشارة وراثية.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). All testing performed in a DHA‑regulated facility (License: 9834453).
Support & WhatsApp: +971 54 548 8731
This page complies with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE Child Protection Law (CDS 2026), and UAE PDPL for data privacy.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians